Category: Prostate Cancer

Emerging research shows genomic classifier scores from prostate cancer biopsies may offer clues about recurrence risks following focal therapy. While not yet available for routine use, this insights could be a valuable tool in future treatment decisions. keep reading

Detecting prostate cancer early makes nearly 100% treatment success possible, often with fewer side effects. Routine PSA screening and modern imaging tools help identify cancer while it's still most curable. Skipping annual tests risks missing the critical window for best outcomes. keep reading

How can a simple blood test reveal silent cancer risks? Many men are surprised to learn early prostate cancer often shows no symptoms at all—making questions about warning signs, PSA screening, or family history even more important. Find out how age, genetics, and lifestyle shape the story, and why timing matters for peace of mind. keep reading

Localized prostate cancer presents several effective treatment choices, each with its own benefits and considerations. From surgery and radiation to modern ablation techniques and active surveillance, the best approach depends on cancer characteristics and patient priorities keep reading

PET/MRI combines advanced imaging techniques for superior detection of aggressive and recurrent prostate cancer, offering detailed views and lower radiation exposure compared to PET/CT. It's especially valuable for complex cases and can help avoid unnecessary biopsies. keep reading

Whole Body MRI and PSMA PET-CT scans each offer unique insights into advanced prostate cancer. Discover how these imaging methods compare in finding cancer spread beyond the prostate gland. keep reading

After focal therapy for prostate cancer, annual PSA testing and mpMRI scans work together to spot new cancer activity. This approach offers a balance of cancer control and quality of life, keeping future treatment options open for patients and their doctors. keep reading

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading

Whole Body MRI and PSMA-PET scans are leading tools for detecting prostate cancer that has spread beyond the gland. Recent studies suggest Whole Body MRI may hold a slight edge in accuracy, especially for predicting risk and tracking treatment, while both remain vital for planning care. keep reading

Could where fat collects on the body matter more for cancer risk than overall weight? While researchers have linked high BMI to more aggressive prostate cancer, new measures like A Body Shape Index reveal stronger ties to colon cancer. Evidence remains mixed for prostate cancer, keeping healthy habits as the best defense. keep reading